Treatment for Vascular Pulmonary Congestion

Initial Management Priorities

• The American College of Cardiology recommends oxygen supplementation, intravenous loop diuretics, and vasodilators (nitrates) in patients with adequate blood pressure, along with morphine for symptom relief 1, 2
• Supplemental oxygen to maintain arterial saturation >90% is the first intervention, with high-flow oxygen recommended when capillary oxygen saturation is <90% or PaO2 <60 mmHg 1, 2, 3
• Morphine sulfate should be administered 3 mg IV bolus immediately upon establishing IV access, with repeat dosing as needed for anxiety, restlessness, and dyspnea, inducing venodilation, mild arterial dilation, and reducing heart rate 1, 2, 4
• Nitrates are superior to high-dose diuretics alone for severe pulmonary edema, with nitroglycerin spray 400 mcg (2 puffs) every 5-10 minutes, or sublingual nitroglycerin 0.25-0.5 mg, and IV nitroglycerin starting at 10-20 mcg/min, increasing by 5-10 mcg/min every 3-5 minutes as needed 4, 5, 6
• The European Heart Society recommends starting short-acting ACE inhibitor (captopril 1-6.25 mg) after initial stabilization, providing afterload reduction and long-term mortality benefit 1, 2, 7

Monitoring and Adjunctive Therapies

• Non-invasive ventilation with CPAP or non-invasive positive pressure ventilation is recommended for respiratory rate >20 breaths/min, improving breathlessness, reducing hypercapnia and acidosis, but avoiding if SBP <85 mmHg 3
• Echocardiography should be performed urgently to estimate LV/RV function and exclude mechanical complications 1, 7
• Thromboembolic prophylaxis with LMWH or unfractionated heparin is recommended unless contraindicated 3

Special Considerations

• In hypertensive crisis with pulmonary edema, aim for initial rapid BP reduction of 30 mmHg within minutes, using IV loop diuretics if clear fluid overload present, IV nitroglycerin or nitroprusside for preload/afterload reduction, and considering calcium channel blocker (nicardipine) for diastolic dysfunction, but not attempting to normalize BP acutely 8
• For refractory pulmonary congestion, consider intra-aortic balloon pump insertion and continuous veno-venous hemofiltration may be necessary in severe renal dysfunction with refractory fluid retention 1, 7, 8
• At discharge, patients should be initiated on beta-blockade at low doses for secondary prevention, and long-term aldosterone blockade for post-MI patients with LVEF ≤0.40 and symptomatic heart failure or diabetes 1, 7

Initial Treatment for Acute Heart Failure with Severe Hypertension and Pulmonary Congestion

Rationale for Dual Therapy Approach

• The European Society of Cardiology recommends vasodilators for symptomatic relief when systolic blood pressure is >90 mmHg, and in patients with hypertensive acute heart failure, intravenous vasodilators should be considered as initial therapy to improve symptoms and reduce congestion (Class IIa, Level B recommendation) 9, 10
• Diuretics improve symptoms and are recommended to regularly monitor symptoms, urine output, renal function and electrolytes (Class I, Level C recommendation) 9, 10

Initial Management

• For patients with chronic decompensated heart failure on oral diuretics, the initial IV dose should be at least equivalent to the oral dose, and if diuretic-naïve, start with 20-40 mg IV furosemide 9, 10
• The European Society of Cardiology specifically recommends monitoring blood pressure frequently during administration of vasodilators 9, 10

Inotropic Support

• Inotropic agents are not recommended unless the patient is symptomatically hypotensive or hypoperfused (Class III, Level A recommendation) 9, 11
• Inotropes should only be considered when systolic blood pressure is <90 mmHg with signs of peripheral hypoperfusion 9, 11

Monitoring and Adjunctive Therapies

• Blood pressure should be monitored every 5-15 minutes during vasodilator titration, and urine output should be monitored hourly (target >100-150 mL/h in first 6 hours) 9, 10
• Thromboembolic prophylaxis with low molecular weight heparin is recommended unless contraindicated 9, 10
• Placement of a bladder catheter to monitor urine output is recommended 12